Doctor Slater is Professor and Chair of the Department of Radiation Medicine, Loma Linda University (LLU). He is also the Medical Director and Director of Clinical Affairs for the department at LLUMC and holds appointments at several other hospitals in California.
Doctor Slater’s prime professional pursuit is optimizing radiation therapy, including proton beam irradiation. Doctor Slater has been involved with the design of treatment protocols and clinical research investigations ever since hospital-based proton radiation treatment was pioneered at LLU in 1990.
He is a member of several academic and clinical committees at LLU, including the Cancer Committee, the Radiation Research Committee, the Clinical Research Scientific Review Committee and the Medical Staff Executive Committee. He is a member of several professional societies including:
• American College of Radiology
• American Radium Society
• American Society of Clinical Oncology
• American Society for Therapeutic Radiology and Oncology
• Particle Therapy Co-Operative Group
Doctor Slater is a graduate of LLU School of Medicine. He took residency training in radiation oncology at M.D. Anderson Hospital and Tumor Institute, Houston, Texas, followed by fellowships in radiation oncology at Harvard Medical School, Massachusetts General Hospital and Harvard Cyclotron Laboratory in Boston, Mass.
He has authored and co-authored many articles in peer-reviewed journals as well as several book chapters and presentations at professional meetings. Most of these works involve proton radiation therapy and its applications at LLUMC. Doctor Slater conducts research to further enhance the precision of protons via improved delivery systems such as robotic positioning and active beam scanning, both of which extend proton treatment to a greater number of patients with a wider variety of cancers and other diseases. He is also involved in research to apply proton radiation in new ways such as reducing treatment time by means of hypofractionation and employing protons for radiosurgical and palliative applications.